New psoriasis drug is more effective than current treatment A phase II clinical trial shows that a new psoriasis drug called guselkumab has greater efficacy than the current standard of care for the chronic skin condition. Psoriasis is an immune-mediated disease that causes itchy, dry and red skin. It also increases a patient's risk for depression, heart disease and diabetes, among other conditions.
Phthalates: 'Safer' replacements for harmful chemical in plastics may be as risky to human health According to a new series of studies, two chemicals increasingly used during manufacturing to strengthen plastic wrap, soap, cosmetics, and processed food containers have been linked to a rise in risk of high blood pressure and diabetes in children and adolescents.
Why social workers aren't discussing religion, spirituality with clients Licensed clinical social workers, who account for the largest number of clinically trained helping professionals, believe that discussions about their clients' religion and spirituality can often lead to improved health and mental health, but practitioners are not integrating these conversations into their counseling sessions.
Gene therapy restores hearing in deaf mice Using gene therapy, researchers have restored hearing in mice with a genetic form of deafness. More than 70 different genes are known to cause deafness when mutated. The scientists focused on a gene called TMC1 because it is a common cause of genetic deafness, accounting for 4 to 8 percent of cases, and encodes a protein that plays a central role in hearing, helping convert sound into electrical signals that travel to the brain.
Deaths attributed to low levels of education: Lack of education as deadly as smoking A new study estimates the number of deaths that can be linked to differences in education, and finds that variation in the risk of death across education levels has widened considerably